Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

被引：2
|
作者：
Kim, Jean Hee [1 ]
Park, Silvia [2 ]
Kim, Woojun [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Dept Neurol, Coll Med, 222 Banpo daero, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Coll Med, 222 Banpo daero, Seoul, South Korea
来源：
NEUROLOGICAL SCIENCES | 2022年 / 43卷 / 09期
关键词：
D O I：
10.1007/s10072-022-06124-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：5651 / 5653
页数：3
相关论文
共 50 条
  • [21] Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO
    Gelfand, Jeffrey M.
    Cotter, Jennifer
    Klingman, Jeffrey
    Huang, Eric J.
    Cree, Bruce A. C.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (03):
  • [22] Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients
    Chan, Jillian K.
    de Lapiscina, Elena Hernandez Martinez
    Taylor, Carolyn
    Nguyen, Ai-Lan
    Alba-Arbalat, Salut
    Devonshire, Virginia
    Sayao, Ana-Luiza
    Carruthers, Robert
    Costello, Fiona
    Traboulsee, Anthony
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2020, 40 (01) : 37 - 43
  • [23] Auto-immune hepatitis in a patient with multiple sclerosis treated with alemtuzumab
    Souraya El Sankari
    Géraldine Dahlqvist
    Laurent Monino
    Vincent van Pesch
    Acta Neurologica Belgica, 2018, 118 : 331 - 333
  • [24] Auto-immune hepatitis in a patient with multiple sclerosis treated with alemtuzumab
    El Sankari, Souraya
    Dahlqvist, Geraldine
    Monino, Laurent
    van Pesch, Vincent
    ACTA NEUROLOGICA BELGICA, 2018, 118 (02) : 331 - 333
  • [25] Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis
    Rosario Le Moli
    Marco Russo
    Pasqualino Malandrino
    Veronica Vella
    Antonino Belfiore
    Francesco Frasca
    Hormones, 2021, 20 : 161 - 165
  • [26] Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis
    Le Moli, Rosario
    Russo, Marco
    Malandrino, Pasqualino
    Vella, Veronica
    Belfiore, Antonino
    Frasca, Francesco
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 20 (01): : 161 - 165
  • [27] Lack of CD4+T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses
    Rolla, Simona
    De Mercanti, Stefania Federica
    Bardina, Valentina
    Horakova, Dana
    Habek, Mario
    Adamec, Ivan
    Cocco, Eleonora
    Annovazzi, Pietro
    Vladic, Anton
    Novelli, Francesco
    Durelli, Luca
    Clerico, Marinella
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 313 : 89 - 91
  • [28] PREGNANCY OUTCOMES IN ALEMTUZUMAB-TREATED PATIENTS WITH RRMS
    Rog, David
    Chambers, Christina
    McCombe, Pamela
    Otero, Susana
    Hellwig, Kerstin
    Margolin, David
    Thangavelu, Karthinathan
    Oh, Jiwon
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [29] Cryptogenic cerebral venous thrombosis in a multiple-sclerosis-patient treated with Alemtuzumab
    Gasparini, Sara
    Russo, Margherita
    Dattola, Vincenzo
    Ferlazzo, Edoardo
    Aguglia, Umberto
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [30] Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab
    Ines Gaitan, Maria
    Celica Ysrraelit, Maria
    Correale, Jorge
    JAMA NEUROLOGY, 2017, 74 (09) : 1143 - 1144
12345